Update in paroxysmal nocturnal hemoglobinuria.
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Peter
P
Hillmen
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D006457:Hemoglobinuria, Paroxysmal / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D011379:Prognosis; D012106:Research
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; C481642:eculizumab